Robert S. Benjamin, MD | Authors


Chemotherapy for Soft-Tissue Sarcomas

January 15, 2015

In patients with high-risk localized disease, the use of systemic chemotherapy should be strongly considered to delay recurrence and/or reduce the patient’s risk of developing metastatic disease. In patients with metastatic disease, systemic chemotherapy remains the mainstay of treatment.